期刊
ONCOLOGIST
卷 11, 期 3, 页码 261-262出版社
WILEY
DOI: 10.1634/theoncologist.11-3-261
关键词
oxaliplatin; acute myelogenous leukemia; therapy-related leukemia; colon adenocarcinoma therapy; chemotherapy side effects
类别
A 56-year-old woman diagnosed with a poorly differentiated cecal adenocarcinoma with metastases to ovaries, omentum, and sigmoid colon went into remission after 12 cycles of infusional 5-fluorouracil, luecovorin, and oxaliplatin (FOLFOX-4 regimen). Thirteen months later, a pelvic recurrence was diagnosed, and the patient received nine cycles of FOLFOX-6 plus bevacizumab, resulting in a clinical complete response but the development of pancytopenia. Bone marrow biopsy was consistent with therapy-related acute myelogeuous leukemia. Chromosome analysis showed structural rearrangements with partial deletions of the long arms of chromosomes 5,7,20, and 21, as well as trisomy of chromosome 8 and losses of chromosomes 3 and 11. Induction chemotherapy led to remission, but the patient died two months later from complications of colon cancer progression. It is likely that the leukemia was related to the oxaliplatin administration.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据